Morana Jovan-Embiricos
CIK 1575745 · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.92M
Companies
5
Total Filings
23
Lifetime Open-Market Net
$37.47M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KLRS | Director | — | $4.33 | — | $0 | 2 | 2026-06-04 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | Director | 967,875 | $9.81 | $9.49M | $48.59M | 11 | 2024-06-07 |
| CGEM | Director | 578,214 | $13.70 | $7.92M | -$10.70M | 4 | 2022-06-28 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | 10%+ Owner | 90,026 | $1.48 | $133.2K | -$412.5K | 1 | 2019-10-24 |
| Radius Health, Inc. (RDUS) Delisted | Director | 0 | $30.00 | $0 | $0 | 5 | 2015-01-20 |
Recent Filings · Page 2 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-15 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −800 | -$19.8K | EDGAR |
| 2021-11-09 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −12,196 | -$302.5K | EDGAR |
| 2021-10-29 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −2,200 | -$54.5K | EDGAR |
| 2021-10-25 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −13,592 | -$337.0K | EDGAR |
| 2021-05-27 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-08-06 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Mixed | +18,379,398 | $49.30M | EDGAR |
| 2020-07-31 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-10-24 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Sell (S) | −27,216 | -$412.5K | EDGAR |
| 2015-01-20 | Radius Health, Inc. (RDUS) Delisted | Other (J) | — | $0 | EDGAR |
| 2015-01-15 | Radius Health, Inc. (RDUS) Delisted | Other (J) | −587,500 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.